News
Shares of Solano Therapeutics are surging after winning US FDA approval for its new drug to treat excessive ... ripping higher by more than 40% during today's activity. 00:33 Speaker B Yeah ...
The US Food and Drug Administration (FDA) has approved fitusiran (Qfitlia, Sanofi) for bleeding prophylaxis in patients aged 12 years or older ... levels between 15% and 35% of normal using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results